$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Antibodies to a novel EGF-receptor related protein (ERRP) 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07K-016/00
출원번호 US-0302868 (2002-11-25)
발명자 / 주소
  • Majumdar,Adhip P. N.
  • Sarkar,Fazlul H.
출원인 / 주소
  • Majumdar,Adhip P. N.
  • Sarkar,Fazlul H.
대리인 / 주소
    Blank Rome LLP
인용정보 피인용 횟수 : 2  인용 특허 : 66

초록

This invention relates to ERRP (EGF-Receptor Related Protein) specific antibodies that could be used 1) to study the functional properties of ERRP and; 2) as a diagnostic and prognostic tool for malignancies. Preferably, the antibody reacts with a segment of ERRP containing 15 amino acids (SEQ ID NO

대표청구항

What is claimed is: 1. An antibody that specifically binds to the polypeptide of SEQ ID NO: 3. 2. The antibody of claim 1, wherein the antibody is monoclonal. 3. The antibody of claim 1, wherein the antibody is polyclonal. 4. An antibody that specifically binds to the polypeptide of SEQ ID NO

이 특허에 인용된 특허 (66)

  1. Tang Peng Cho ; Sun Li ; McMahon Gerald, 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease.
  2. Tang Peng Cho ; Sun Li ; McMahon Gerald, 3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease.
  3. Tang Peng Cho ; Sun Li ; McMahon Gerald, 3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease.
  4. Tang Peng Cho ; Sun Li ; McMahon Gerald, 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease.
  5. Tang Peng Cho ; Sun Li ; McMahon Gerald, 3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors.
  6. Tang Peng Cho ; Sun Li ; McMahon Gerald, 3-heteroaryl-2-indolinone compounds for the treatment of disease.
  7. Barker Andrew John,GBX, 4-anilinoquinazoline derivatives bearing a heteroaryl substituted at the 6-position and possessing anti-cell-proliferati.
  8. Brown Dearg Sutherland,GBX ; Morris Jeffrey James,GBX ; Thomas Andrew Peter,GBX, Aniline derivatives.
  9. Chada Sunil (Vista CA) Bodner Mordechai (San Diego CA) Jolly Douglas J. (La Jolla CA) Barber Jack R. (San Diego CA) DeJesus Caty E. (San Diego CA), Anti-cancer immunotherapeutics.
  10. Lippman Marc E. ; Lupu Ruth, Antibodies to ligand growth factors.
  11. Plowman Gregory D., Assay for agents active in proliferative disorders.
  12. Tang Peng Cho ; McMahon Gerald, Benzopyran compounds and methods for their use.
  13. Tang Peng Cho ; Sun Li ; McMahon Gerald, Benzylidene-Z-indoline compounds for the treatment of disease.
  14. Tang Peng Cho ; Sun Li ; Nematalla Asaad S. ; McMahon Gerald, Certain acrylonitrile-sulfonamide derivatives.
  15. Lohmann Jean-Jacques Marcel,FRX ; Hennequin Laurent Francois Andre,FRX ; Thomas Andrew Peter,GBX, Chemical compounds.
  16. Greene Mark I. ; Qian Xiaolan, Compositions and methods of treating tumors.
  17. Tang Peng Cho, Compounds and methods for inhibiting hyper-proliferative cell growth.
  18. Tang Peng Cho, Compounds and methods for inhibiting hyper-proliferative cell growth.
  19. Tang Peng Cho, Compounds and methods for inhibiting hyper-proliferative cell growth.
  20. Connors Richard W. (Saline MI), EGF receptor truncates.
  21. Parandoosh Zahra, Fluorescence-based assays for measuring cell proliferation.
  22. Kriegler Michael ; Perez Carl F., Gene fusion encoding a hypersecretor protein.
  23. Hudziak Robert Michael ; Shepard H. Michael ; Ullrich Axel,DEX, HER2 extracellular domain.
  24. Kriegler Michael ; Perez Carl F., Human til cells expressing recombinant TNF prohormone.
  25. Hudziak Robert M. ; Ullrich Axel ; Fendly Brian M., In vivo tumor detection assay.
  26. Kriegler Michael ; Perez Carl F., Infective protein delivery system.
  27. Kriegler Michael ; Perez Carl F., Infective protein delivery system.
  28. Eberlein Timothy J. (Dover MA) Peoples George E. (Newtonville MA) Yoshino Ichiro (Brookline MA) Goedegebuure Peter (Brighton MA), Isolated antigenic oncogene peptide fragments and uses.
  29. Lippman Marc E. ; Lupu Ruth, Ligand growth factor gp30 that binds to the erbB-2 receptor protein and induces cellular responses.
  30. Lippman Marc E. (Bethesda MD) Lupu Ruth (Gaithersburg MD), Ligand growth factors that bind to the erbB-2 receptor protein and induce cellular responses.
  31. Wang Mary Ge ; George ; Jr. Albert Louis ; Light Elizabeth Sophia, Method for the detection of chromosome structural abnormalities by in situ hybridization to fixed tissue.
  32. Barber Jack R. ; Gruber Harry E. ; Jolly Douglas J., Method for treating a metastatic carcinoma using a conditionally lethal gene.
  33. Kmiecik Thomas E. ; Vande Woude George F., Method of stimulating bone marrow regeneration.
  34. Chen Hui ; Gazit Aviv,ILX ; Hirth Klaus Peter ; Mann Elaina ; Shawver Laura K. ; Tsai Jianming ; Tang Peng Cho, Methods and compositions for inhibiting cell proliferative disorders.
  35. Chen Hui ; Gazit Aviv,ILX ; Levitzki Alexander,ILX ; Hirth Klaus Peter ; Mann Elaina ; Shawver Laura K. ; Tsai Jianming ; Tang Peng Cho, Methods and compositions for inhibiting cell proliferative disorders.
  36. Goldsmith Mark A. ; Ralston Robert O., Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders.
  37. Goldsmith Mark A. ; Ralston Robert O., Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders.
  38. Cheever Martin A. ; Disis Mary L., Methods for eliciting or enhancing reactivity to HER-2/neu protein.
  39. Hung Mien-Chie ; Yu Di-Hua ; Matin Angabin ; Zhang Yujiao Joe, Methods for the suppression of neu mediated phenotype in tumors.
  40. Hung Mien-Chie (Houston TX) Yu Di-Hua (Houston TX) Matin Angabin (Houston TX), Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen.
  41. Hung Mien-Chie (Houston TX) Yu Di-Hua (Houston TX) Matin Angahin (Houston TX) Zhang Yujiao Joe (Houston TX), Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen.
  42. Hung Mien-Chie (Houston TX) Yu Di-Hua (Houston TX), Methods for the suppression of neu mediated tumors by the adenoviral EIA gene.
  43. Margolis Benjamin Lewis ; Schlessinger Joseph ; Yajnik Vijay, Methods for treatment or diagnosis of diseases or disorders associated with an APB domain.
  44. Hudziak Robert M. (Corvallis OR) Shepard H. Michael (Rancho Santa Fe CA) Ullrich Axel (Portola Valley CA) Fendly Brian M. (Half Moon Bay CA), Monoclonal antibodies directed to the HER2 receptor.
  45. Hudziak Robert M. ; Shepard H. Michael ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the HER2 receptor.
  46. Hudziak Robert M. ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the HER2 receptor.
  47. Hudziak Robert M. ; Shepard H. Michael ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the her2 receptor.
  48. Himmelsbach Frank,DEX ; Dahmann Georg,DEX ; von Ruden Thomas,ATX ; Metz Thomas,ATX, Pyrimido [5, 4-d] pyrimidines, pharmaceuticals containing these compounds, their use and processes for their preparation.
  49. Barker Andrew John,GBX ; Johnstone Craig,GBX, Quinazoline compounds.
  50. Barker Andrew John,GBX, Quinazoline derivative.
  51. Baker Andrew John,GBX, Quinazoline derivatives.
  52. Barker Andrew John,GBX, Quinazoline derivatives.
  53. Tang Peng Cho (Moraga CA) McMahon Gerald (Kenwood CA) Sun Li (Foster City CA), Quinoline compounds.
  54. Kriegler Michael (Ambler PA) McCormick Francis P. (Albany CA), Retroviral vectors expressing cytokines.
  55. Kriegler Michael (Ambler PA) McCormick Francis P. (Albany NY), Retroviral vectors expressing tumor necrosis factor (TNF).
  56. Kamb Carl Alexander, Selection systems and methods for identifying genes and gene products involved in cell proliferation.
  57. Lohmann Jean-Jacques Marcel,FRX ; Hennequin Laurent Francois Andre,FRX ; Thomas Andrew Peter,GBX, Substituted quinazolines.
  58. Kriegler Michael ; Perez Carl F., TNF deletion muteins.
  59. Tang Peng Cho ; Nematalla Asaad S. ; McMahon Gerald, Thienyl compounds for inhibition of cell proliferative disorders.
  60. Hirth Klaus Peter (San Francisco CA) Schwartz Donna Pruess (San Mateo CA) Mann Elaina (Alameda CA) Shawver Laura Kay (San Francisco CA) Keri Gyorgi (Budapest HUX) Szekely Istvan (Dunakeszi HUX) Bajor, Treatment of platelet derived growth factor related disorders such as cancers.
  61. Hirth Klaus Peter ; Schwartz Donna Pruess ; Mann Elaina ; Shawver Laura Kay ; Keri Gyorgi,HUX ; Szekely Istvan,HUX ; Bajor Tamas,HUX ; Haimichael Janis,HUX ; Orfi Laszlo,HUX ; Levitzki Alex,ILX ; Gaz, Treatment of platelet derived growth factor related disorders such as cancers.
  62. Hirth Klaus Peter ; Schwartz Donna Pruess ; Mann Elaina ; Shawver Laura Kay ; Ullrich Axel,DEX ; Lammers Reiner,DEX, Treatment of platelet derived growth factor related disorders such as cancers.
  63. Hirth Klaus Peter ; Shawver Laura Kay ; Keri Gyorgi,HUX ; Szekely Istvan,HUX ; Haimichael Janis,HUX ; Ullrich Axel,DEX ; Lammers Reiner,DEX, Treatment of platelet derived growth factor related disorders such as cancers.
  64. Tang Peng Cho ; Sun Li ; Nematalla Asaad S. ; McMahon Gerald, Tyrphostin like compounds.
  65. Tang Peng Cho ; McMahon Gerald, Urea- and thiourea-type compounds.
  66. King C. Richter ; Kraus Matthias H. ; Aaronson Stuart A., erbB-2 gene segments, probes, recombinant DNA and kits for detection.

이 특허를 인용한 특허 (2)

  1. D'Angelo, Marina; Selim, Abdulhafez A., Compositions and methods for inhibition of MMP8:MMP8-substrate interactions.
  2. D'Angelo, Marina; Selim, Abdulhafez, Compounds for inhibition of MMP13-substrate interactions and methods of use thereof to treat osteoarthritis and cartilage degeneration.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로